Azoy Alexander 4
4 · Arcus Biosciences, Inc. · Filed Sep 5, 2025
Insider Transaction Report
Form 4
Azoy Alexander
Chief Accounting Officer
Transactions
- Sale
Common Stock
2025-09-05$11.88/sh−1,579$18,758→ 30,194 total
Footnotes (3)
- [F1]Consists of 1,579 shares purchased on 5/30/2025 through the Company's Employee Stock Purchase Plan.
- [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 6, 2025.
- [F3]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.55 to $12.22, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.